Satellos Bioscience MSLE
NASDAQ MSLE
$8.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Change in Acquisitions & Divestments (2026)

Updated

Satellos Bioscience's Change in Acquisitions & Divestments came in at -$7.22 million for the quarter ended Jun 30, 2026.

Analysis

Satellos Bioscience (MSLE) Change in Acquisitions & Divestments (2026) Analysis & Trends

For the year ended Dec 31, 2025, Satellos Bioscience's Change in Acquisitions & Divestments was -$23.37 million.

  • Going back by year, Change in Acquisitions & Divestments was -$27.42 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Satellos Bioscience 131.40 Mn 131.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.22 Mn
Mar 31, 2026 -43.88 Mn
API Access

Satellos Bioscience Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=MSLE&period=max&api_key=YOUR_API_KEY